Загрузка...
Development of a High-Flow Nasal Cannula and Pharmaceutical Aerosol Combination Device
Background: Aerosol drug delivery to the lungs is known to be very inefficient during all forms of noninvasive ventilation, especially when the aerosol is administered simultaneously with high-flow nasal cannula (HFNC) therapy. The objective of this study was to develop a new combination device base...
Сохранить в:
| Опубликовано в: : | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mary Ann Liebert, Inc., publishers
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6685196/ https://ncbi.nlm.nih.gov/pubmed/30855199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2018.1488 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|